Intracoastal Capital LLC Reports 9.99% Passive Stake in Bluejay Diagnostics, Inc. via Warrants

On June 5, 2026, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G regarding their holdings in Bluejay Diagnostics, Inc. (BJDX). The reporting persons disclosed beneficial ownership of 114,840 shares of common stock, representing a 9.99% ownership stake. This ownership is derived from shares issuable upon the exercise of warrants. The filing details multiple warrants held by Intracoastal, several of which include "blocker provisions" that prevent the reporting persons from exercising warrants if such an action would result in beneficial ownership exceeding 4.99% or 9.99% of the outstanding common stock. Without these contractual limitations and assuming all warrants were currently exercisable, the group would potentially hold 1,155,243 shares. The filing indicates that the securities were acquired for investment purposes and not with the intent to influence or change the control of the issuer. This initial 13G filing establishes the group's significant passive position in the clinical diagnostics company.